|
1
|
Bommer J: Prevalence and socio-economic
aspects of chronic kidney disease. Nephrol Dial Transpl. 11:8–12.
2002. View Article : Google Scholar
|
|
2
|
Decleves AE and Sharma K: Novel targets of
antifibrotic and anti-inflammatory treatment in CKD. Nat Rev
Nephrol. 10:257–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lv W, Booz GW, Wang Y, Fan F and Roman RJ:
Inflammation and renal fibrosis: Recent developments on key
signaling molecules as potential therapeutic targets. Eur J
Pharmacol. 820:65–76. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Viehmann SF, Bohner AMC, Kurts C and
Brahler S: The multifaceted role of the renal mononuclear phagocyte
system. Cell Immunol. 330:97–104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nelson PJ, Rees AJ, Griffin MD, Hughes J,
Kurts C and Duffield J: The renal mononuclear phagocytic system. J
Am Soc Nephrol. 23:194–203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao Q, Wang Y, Wang XM, Lu J, Lee VW, Ye
Q, Nguyen H, Zheng G, Zhao Y, Alexander SI, et al: Renal F4/80+
CD11c+ mononuclear phagocytes display phenotypic and functional
characteristics of macrophages in health and in adriamycin
nephropathy. J Am Soc Nephrol. 26:349–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang PM, Nikolic-Paterson DJ and Lan HY:
Macrophages: Versatile players in renal inflammation and fibrosis.
Nat Rev Nephrol. 15:144–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y and Harris DC: Macrophages in renal
disease. J Am Soc Nephrol. 22:21–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan B, Liu G, Jiang Z and Zheng D:
Regulation of renal fibrosis by macrophage polarization. Cell
Physiol Biochem. 35:1062–1069. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Locati M, Curtale G and Mantovani A:
Diversity, mechanisms, and significance of macrophage plasticity.
Annu Rev Pathol. 15:123–147. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Viola A, Munari F, Sanchez-Rodriguez R,
Scolaro T and Castegna A: The metabolic signature of macrophage
responses. Front Immunol. 10:14622019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim Y, Nurakhayev S, Nurkesh A,
Zharkinbekov Z and Saparov A: Macrophage polarization in cardiac
tissue repair following myocardial infarction. Int J Mol Sci.
22:27152021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu P, Liu Y and Zhang J: Review: The role
and mechanisms of macrophage autophagy in sepsis. Inflammation.
42:6–19. 2018. View Article : Google Scholar
|
|
14
|
Kadomoto S, Izumi K and Mizokami A:
Macrophage polarity and disease control. Int J Mol Sci. 23:1442021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C, Xu MM, Wang K, Adler AJ, Vella AT
and Zhou B: Macrophage polarization and meta-inflammation. Transl
Res. 191:29–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bashir S, Sharma Y, Elahi A and Khan F:
Macrophage polarization: The link between inflammation and related
diseases. Inflamm Res. 65:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Q, Sun S, Wei L, Liu M, Liu H, Liu T,
Zhou Y, Jia Q, Wang D, Yang Z, et al: Twist1 regulates macrophage
plasticity to promote renal fibrosis through galectin-3. Cell Mol
Life Sci. 79:1372022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ko GJ, Boo CS, Jo SK, Cho WY and Kim HK:
Macrophages contribute to the development of renal fibrosis
following ischaemia/reperfusion-induced acute kidney injury.
Nephrol Dial Transplant. 23:842–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fogo AB: Progression and potential
regression of glomerulosclerosis. Kidney Int. 59:804–819. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rodrignez-Pena A, Prieto M, Duwel A, Rivas
JV, Eleno N, Pérez-Barriocanal F, Arévalo M, Smith JD, Vary CP,
Bernabeu C and López-Novoa JM: Up-regulation of endoglin, a
TGF-beta-binding protein, in rats with experimental renal fibrosis
induced by renal mass reduction. Nwphrol Dial Transplant. 16 (Suppl
1):34–39. 2001. View Article : Google Scholar
|
|
21
|
Tan X, Li Y and Liu Y: Therapeutic role
and potential mechanisms of active Vitamin D in renal interstitial
fibrosis. J Steroid Biochem Mol Biol. 103:491–496. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lopez-Novoa JM, Martinez-Salgado C,
Rodriguez-Pena AB and Lopez-Hernandez FJ: Common pathophysiological
mechanisms of chronic kidney disease: Therapeutic perspectives.
Pharmacol Ther. 128:61–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chevalier RL, Forbes MS and Thornhill BA:
Ureteral obstruction as a model of renal interstitial fibrosis and
obstructive nephropathy. Kidney Int. 75:1145–1152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grande MT, Perez-Barriocanal F and
Lopez-Novoa JM: Role of inflammation in tubulo-interstitial damage
associated to obstructive nephropathy. J Inflamm (Lond). 7:192010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang PH, Cenedeze MA, Campanholle G,
Malheiros DM, Torres HA, Pesquero JB, Pacheco-Silva A and Camara
NO: Deletion of bradykinin B1 receptor reduces renal fibrosis. Int
Immunopharmacol. 9:653–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nishida M and Hamaoka K: Macrophage
phenotype and renal fibrosis in obstructive nephropathy. Nephron
Exp Nephrol. 110:e31–e36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duffield JS, Ware CF, Ryffel B and Savill
J: Suppression by apoptotic cells defines tumor necrosis
factor-mediated induction of glomerular mesangial cell apoptosis by
activated macrophages. Am J Pathol. 159:1397–1404. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kipari T and Hughes J: Macrophage-mediated
renal cell death. Kidney Int. 61:760–761. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lange-Sperandio B, Cachat F, Thornhill BA
and Chevalier RL: Selectins mediate macrophage infiltration in
obstructive nephropathy in newborn mice. Kidney Int. 61:516–524.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fadok VA, Bratton DL, Konowal A, Freed PW,
Westcott JY and Henson PM: Macrophages that have ingested apoptotic
cells in vitro inhibit proinflammatory cytokine production through
autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J
Clin Investigation. 101:890–898. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song E, Ouyang N, Horbelt M, Antus B, Wang
M and Exton MS: Influence of alternatively and classically
activated macrophages on fibrogenic activities of human
fibroblasts. Cell Immunol. 204:19–28. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang D, Xiong M, Chen C, Du L, Liu Z, Shi
Y, Zhang M, Gong J, Song X, Xiang R, et al: Legumain, an
asparaginyl endopeptidase, mediates the effect of M2 macrophages on
attenuating renal interstitial fibrosis in obstructive nephropathy.
Kidney Int. 94:91–101. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishida M, Okumura Y, Fujimoto S,
Shiraishi I, Itoi T and Hamaoka K: Adoptive transfer of macrophages
ameliorates renal fibrosis in mice. Biochem Biophys Res Commun.
332:11–16. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Steiger S, Kumar SV, Honarpisheh M, Lorenz
G, Gunthner R, Romoli S, Grobmayr R, Susanti HE, Potempa J, Koziel
J, et al: Immunomodulatory molecule IRAK-M balances macrophage
polarization and determines macrophage responses during renal
fibrosis. J Immunol. 199:1440–1452. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Figueiredo KA, Rossi G and Cox ME: Relaxin
promotes clustering, migration, and activation states of
mononuclear myelocytic cells. Ann N Y Acad Sci. 1160:353–360. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lan HY: Role of macrophage migration
inhibition factor in kidney disease. Nephron Exp Nephrol.
109:e79–e83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li MO and Flavell RA: Contextual
regulation of inflammation: A duet by transforming growth
factor-beta and interleukin-10. Immunity. 28:468–476. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tregear GW, Bathgate RA, Hossain MA, Lin
F, Zhang S, Shabanpoor F, Scott DJ, Ma S, Gundlach AL, Samuel CS
and Wade JD: Structure and activity in the relaxin family of
peptides. Ann N Y Acad Sci. 1160:5–10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Samuel CS, Hewitson TD, Unemori EN and
Tang ML: Drugs of the future: The hormone relaxin. Cell Mol Life
Sci. 64:1539–1557. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Samuel CS and Hewitson TD: Relaxin and the
progression of kidney disease. Curr Opin Nephrol Hypertens.
18:9–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen L, Sha ML, Li D, Zhu YP, Wang XJ,
Jiang CY, Xia SJ and Shao Y: Relaxin abrogates renal interstitial
fibrosis by regulating macrophage polarization via inhibition of
Toll-like receptor 4 signaling. Oncotarget. 8:21044–21053. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Anders HJ and Ryu M: Renal
microenvironments and macrophage phenotypes determine progression
or resolution of renal inflammation and fibrosis. Kidney Int.
80:915–925. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bohlson SS, O'Conner SD, Hulsebus HJ, Ho
MM and Fraser DA: Complement, c1q, and c1q-related molecules
regulate macrophage polarization. Front Immunol. 5:4022014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cui J, Wu X, Song Y, Chen Y and Wan J:
Complement C3 exacerbates renal interstitial fibrosis by
facilitating the M1 macrophage phenotype in a mouse model of
unilateral ureteral obstruction. Am J Physiol Renal Physiol.
317:F1171–F1182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Brown NJ: Contribution of aldosterone to
cardiovascular and renal inflammation and fibrosis. Nat Rev
Nephrol. 9:459–469. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Blasi ER, Rocha R, Rudolph AE, Blomme EA,
Polly ML and McMahon EG: Aldosterone/salt induces renal
inflammation and fibrosis in hypertensive rats. Kidney Int.
63:1791–1800. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kang YS, Ko GJ, Lee MH, Song HK, Han SY,
Han KH, Kim HK, Han JY and Cha DR: Effect of eplerenone, enalapril
and their combination treatment on diabetic nephropathy in type II
diabetic rats. Nephrology Dialysis Transplantation. 24:73–84. 2008.
View Article : Google Scholar
|
|
48
|
Yuan X, Wang X, Li Y, Li X, Zhang S and
Hao L: Aldosterone promotes renal interstitial fibrosis via the
AIF-1/AKT/mTOR signaling pathway. Mol Med Rep. 20:4033–4044.
2019.PubMed/NCBI
|
|
49
|
Nakamura T, Girerd S, Jaisser F and
Barrera-Chimal J: Nonepithelial mineralocorticoid receptor
activation as a determinant of kidney disease. Kidney Int Suppl
(2011). 12:12–18. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fiebeler A, Nussberger J, Shagdarsuren E,
Rong S, Hilfenhaus G, Al-Saadi N, Dechend R, Wellner M, Meiners S,
Maser-Gluth C, et al: Aldosterone synthase inhibitor ameliorates
angiotensin II-induced organ damage. Circulation. 111:3087–3094.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lea WB, Kwak ES, Luther JM, Fowler SM,
Wang Z, Ma J, Fogo AB and Brown NJ: Aldosterone antagonism or
synthase inhibition reduces end-organ damage induced by treatment
with angiotensin and high salt. Kidney Int. 75:936–944. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Luther JM, Luo P, Wang Z, Cohen SE, Kim
HS, Fogo AB and Brown NJ: Aldosterone deficiency and
mineralocorticoid receptor antagonism prevent angiotensin
II-induced cardiac, renal, and vascular injury. Kidney Int.
82:643–651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ma J, Weisberg A, Griffin JP, Vaughan DE,
Fogo AB and Brown NJ: Plasminogen activator inhibitor-1 deficiency
protects against aldosterone-induced glomerular injury. Kidney Int.
69:1064–1072. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang W, Xu C, Kahng KW, Noble NA, Border
WA and Huang Y: Aldosterone and TGF-β1synergistically increase
PAI-1 and decrease matrix degradation in rat renal mesangial and
fibroblast cells. Am J Physiol Renal Physiol. 294:F1287–F1295.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sillen M and Declerck PJ: Targeting PAI-1
in cardiovascular disease: Structural insights Into PAI-1
functionality and inhibition. Front Cardiovasc Med. 7:6224732020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Leroy V, De Seigneux S, Agassiz V, Hasler
U, Rafestin-Oblin ME, Vinciguerra M, Martin PY and Féraille E:
Aldosterone activates NF-kappaB in the collecting duct. J Am Soc
Nephrol. 20:131–144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lee H, Fessler MB, Qu P, Heymann J and
Kopp JB: Macrophage polarization in innate immune responses
contributing to pathogenesis of chronic kidney disease. BMC
Nephrol. 21:2702020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Patel V, Joharapurkar A and Jain M: Role
of mineralocorticoid receptor antagonists in kidney diseases. Drug
Dev Res. 82:341–363. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Martin-Fernandez B, Rubio-Navarro A,
Cortegano I, Ballesteros S, Alia M, Cannata-Ortiz P,
Olivares-Alvaro E, Egido J, de Andres B, Gaspar ML, et al:
Aldosterone induces renal fibrosis and inflammatory M1-macrophage
subtype via mineralocorticoid receptor in rats. PLoS One.
11:e01459462016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Malik S, Suchal K, Gamad N, Dinda AK, Arya
DS and Bhatia J: Telmisartan ameliorates cisplatin-induced
nephrotoxicity by inhibiting MAPK mediated inflammation and
apoptosis. Eur J Pharmacol. 748:54–60. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sindhu G, Nishanthi E and Sharmila R:
Nephroprotective effect of vanillic acid against cisplatin induced
nephrotoxicity in wistar rats: A biochemical and molecular study.
Environ Toxicol Pharmacol. 39:392–404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ozkok A and Edelstein CL: Pathophysiology
of cisplatin-induced acute kidney injury. Biomed Res Int.
2014:9678262014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Jaiman S, Sharma AK, Singh K and Khanna D:
Signalling mechanisms involved in renal pathological changes during
cisplatin-induced nephropathy. Eur J Clin Pharmacol. 69:1863–1874.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Huen SC and Cantley LG: Macrophages in
renal injury and repair. Annu Rev Physiol. 79:449–469. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yuasa T, Juniantito V, Ichikawa C, Yano R,
Izawa T, Kuwamura M and Yamate J: Thy-1 expression, a possible
marker of early myofibroblast development, in renal
tubulointerstitial fibrosis induced in rats by cisplatin. Exp
Toxicol Pathol. 65:651–659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Terada N, Karim MR, Izawa T, Kuwamura M
and Yamate J: Expression of beta-catenin in regenerating renal
tubules of cisplatin-induced kidney failure in rats. Clin Exp
Nephrol. 22:1240–1250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lee S, Huen S, Nishio H, Nishio S, Lee HK,
Choi BS, Ruhrberg C and Cantley LG: Distinct macrophage phenotypes
contribute to kidney injury and repair. J Am Soc Nephrol.
22:317–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sears SM, Vega AA, Kurlawala Z, Oropilla
GB, Krueger A, Shah PP, Doll MA, Miller R, Beverly LJ and Siskind
LJ: F4/80hi resident macrophages contribute to
cisplatin-induced renal fibrosis. Kidney. 360:3818–833. 2022.
|
|
69
|
Yu CC, Chien CT and Chang TC: M2
macrophage polarization modulates epithelial-mesenchymal transition
in cisplatin-induced tubulointerstitial fibrosis. Biomedicine
(Taipei). 6:52016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kim SH, Yu MA, Ryu ES, Jang YH and Kang
DH: Indoxyl sulfate-induced epithelial-to-mesenchymal transition
and apoptosis of renal tubular cells as novel mechanisms of
progression of renal disease. Lab Invest. 92:488–498. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Benedetti G, Fokkelman M, Yan K,
Fredriksson L, Herpers B, Meerman J, van de Water B and de Graauw
M: The nuclear factor κB family member RelB facilitates apoptosis
of renal epithelial cells caused by cisplatin/tumor necrosis factor
α synergy by suppressing an epithelial to mesenchymal
transition-like phenotypic switch. Mol Pharmacol. 84:128–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yamamoto E, Izawa T, Juniantito V,
Kuwamura M, Sugiura K, Takeuchi T and Yamate J: Involvement of
endogenous prostaglandin E2 in tubular epithelial regeneration
through inhibition of apoptosis and epithelial-mesenchymal
transition in cisplatin-induced rat renal lesions. Histol
Histopathol. 25:995–1007. 2010.PubMed/NCBI
|
|
73
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
Inflammatory processes in renal fibrosis. Nat Rev Nephrol.
10:493–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Lech M and Anders HJ: Macrophages and
fibrosis: How resident and infiltrating mononuclear phagocytes
orchestrate all phases of tissue injury and repair. Biochim Biophys
Acta. 1832:989–997. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nikolic-Paterson DJ, Wang S and Lan HY:
Macrophages promote renal fibrosis through direct and indirect
mechanisms. Kidney Int Suppl (2011). 4:34–38. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wijesundera KK, Izawa T, Murakami H,
Tennakoon AH, Golbar HM, Kato-Ichikawa C, Tanaka M, Kuwamura M and
Yamate J: M1- and M2-macrophage polarization in thioacetamide
(TAA)-induced rat liver lesions; a possible analysis for
hepato-pathology. Histol Histopathol. 29:497–511. 2014.PubMed/NCBI
|
|
78
|
Nakagawa M, Karim MR, Izawa T, Kuwamura M
and Yamate J: Immunophenotypical characterization of M1/M2
macrophages and lymphocytes in cisplatin-induced rat progressive
renal fibrosis. Cells. 10:2572021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lee VW and Harris DC: Adriamycin
nephropathy: A model of focal segmental glomerulosclerosis.
Nephrology (Carlton). 16:30–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Nogueira A, Pires MJ and Oliveira PA:
Pathophysiological mechanisms of renal fibrosis: A review of animal
models and therapeutic strategies. In Vivo. 31:1–22. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Pippin JW, Brinkkoetter PT, Cormack-Aboud
FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM,
Marshall CB, Ohse T, et al: Inducible rodent models of acquired
podocyte diseases. Am J Physiol Renal Physiol. 296:F213–F229. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang Y, Wang YP, Zheng G, Lee VW, Ouyang
L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI and Harris
DC: Ex vivo programmed macrophages ameliorate experimental chronic
inflammatory renal disease. Kidney Int. 72:290–299. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Fujimura R, Watanabe H, Nishida K,
Fujiwara Y, Koga T, Bi J, Imafuku T, Kobayashi K, Komori H,
Miyahisa M, et al: α1-Acid glycoprotein attenuates
adriamycin-induced nephropathy via CD163 expressing macrophage
induction. Kidney. 360(1): 343–353. 2020. View Article : Google Scholar
|
|
84
|
Lu J, Cao Q, Zheng D, Sun Y, Wang C, Yu X,
Wang Y, Lee VW, Zheng G, Tan TK, et al: Discrete functions of M2a
and M2c macrophage subsets determine their relative efficacy in
treating chronic kidney disease. Kidney Int. 84:745–755. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Cao Q, Wang Y, Zheng D, Sun Y, Wang Y, Lee
VWS, Zheng G, Tan TK, Ince J, Alexander SI and Harris DC:
IL-10/TGF-beta-modified macrophages induce regulatory T cells and
protect against adriamycin nephrosis. J Am Soc Nephrol. 21:933–942.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Cao Q, Wang Y, Zheng D, Sun Y, Wang C,
Wang XM, Lee VWS, Wang Y, Zheng G, Tan TK, et al: Failed
renoprotection by alternatively activated bone marrow macrophages
is due to a proliferation-dependent phenotype switch in vivo.
Kidney Int. 85:794–806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang JY and Wang WP: B7-H4, a promising
target for immunotherapy. Cell Immunol. 347:1040082020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Umemura N, Saio M, Suwa T, Kitoh Y, Bai J,
Nonaka K, Ouyang GF, Okada M, Balazs M, Adany R, et al:
Tumor-infiltrating myeloid-derived suppressor cells are
pleiotropic-inflamed monocytes/macrophages that bear M1- and
M2-type characteristics. J Leukoc Biol. 83:1136–1144. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wang S, Meng XM, Ng YY, Ma FY, Zhou S,
Zhang Y, Yang C, Huang XR, Xiao J, Wang YY, et al: TGF-β/Smad3
signalling regulates the transition of bone marrow-derived
macrophages into myofibroblasts during tissue fibrosis. Oncotarget.
7:8809–8822. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tavakoli Dargani Z and Singla DK:
Embryonic stem cell-derived exosomes inhibit doxorubicin-induced
TLR4-NLRP3-mediated cell death-pyroptosis. Am J Physiol Heart Circ
Physiol. 317:H460–H471. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Johnson TA and Singla DK: PTEN inhibitor
VO-OHpic attenuates inflammatory M1 macrophages and cardiac
remodeling in doxorubicin-induced cardiomyopathy. Am J Physiol
Heart Circ Physiol. 315:H1236–H1249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhang Y, Liu Y, Liu H and Tang WH:
Exosomes: Biogenesis, biologic function and clinical potential.
Cell Biosci. 9:192019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Jella KK, Nasti TH, Li Z, Malla SR,
Buchwald ZS and Khan MK: Exosomes, their biogenesis and role in
inter-cellular communication, tumor microenvironment and cancer
immunotherapy. Vaccines (Basel). 6:E692018. View Article : Google Scholar
|
|
94
|
Deng S, Zhou X, Ge Z, Song Y, Wang H, Liu
X and Zhang D: Exosomes from adipose-derived mesenchymal stem cells
ameliorate cardiac damage after myocardial infarction by activating
S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization.
Int J Biochem Cell Biol. 114:1055642019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Cai J, Qiao B, Gao N, Lin N and He W: Oral
squamous cell carcinoma-derived exosomes promote M2 subtype
macrophage polarization mediated by exosome-enclosed miR-29a-3p. Am
J Physiol Cell Physiol. 316:C731–C740. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Bardi GT, Smith MA and Hood JL: Melanoma
exosomes promote mixed M1 and M2 macrophage polarization. Cytokine.
105:63–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Singla D, Johnson T and Tavakoli Dargani
Z: Exosome treatment enhances Anti-Inflammatory M2 macrophages and
reduces inflammation-induced pyroptosis in doxorubicin-induced
cardiomyopathy. Cells. 8:12242019. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Alexander M, Hu R, Runtsch MC, Kagele DA,
Mosbruger TL, Tolmachova T, Seabra MC, Round JL, Ward DM and
O'Connell RM: Exosome-delivered microRNAs modulate the inflammatory
response to endotoxin. Nat Commun. 6:73212015. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lorenzen JM, Kaucsar T, Schauerte C,
Schmitt R, Rong S, Hübner A, Scherf K, Fiedler J, Martino F,
Kumarswamy R, et al: MicroRNA-24 antagonism prevents renal ischemia
reperfusion injury. J Am Soc Nephrol. 25:2717–2729. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Trionfini P and Benigni A: MicroRNAs as
master regulators of glomerular function in health and disease. J
Am Soc Nephrol. 28:1686–1696. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lv LL, Feng Y, Wu M, Wang B, Li ZL, Zhong
X, Wu WJ, Chen J, Ni HF, Tang TT, et al: Exosomal miRNA-19b-3p of
tubular epithelial cells promotes M1 macrophage activation in
kidney injury. Cell Death Differ. 27:210–226. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Mulay SR, Linkermann A and Anders HJ:
Necroinflammation in Kidney disease. J Am Soc Nephrol. 27:27–39.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
O'Neal JB, Shaw AD and Billings FT: Acute
kidney injury following cardiac surgery: Current understanding and
future directions. Crit Care. 20:1872016. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Kim MG, Kim SC, Ko YS, Lee HY, Jo SK and
Cho W: The role of M2 macrophages in the progression of chronic
kidney disease following acute kidney injury. PLoS One.
10:e01439612015. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Yang J, Lin SC, Chen G, He L, Hu Z, Chan
L, Trial J, Entman ML and Wang Y: Adiponectin promotes
monocyte-to-fibroblast transition in renal fibrosis. J Am Soc
Nephrol. 24:1644–1659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Negishi H, Ohba Y, Yanai H, Takaoka A,
Honma K, Yui K, Matsuyama T, Taniguchi T and Honda K: Negative
regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad
Sci USA. 102:15989–15994. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lassen S, Lech M, Rommele C, Mittruecker
HW, Mak TW and Anders HJ: Ischemia reperfusion induces IFN
regulatory factor 4 in renal dendritic cells, which suppresses
postischemic inflammation and prevents acute renal failure. J
Immunol. 185:1976–1983. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Lorenz G, Moschovaki-Filippidou F, Wurf V,
Metzger P, Steiger S, Batz F, Carbajo-Lozoya J, Koziel J, Schnurr
M, Cohen CD, et al: IFN regulatory Factor 4 controls post-ischemic
inflammation and prevents chronic kidney disease. Front Immunol.
10:21622019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Liang H, Xu F, Zhang T, Huang J, Guan Q,
Wang H and Huang Q: Inhibition of IL-18 reduces renal fibrosis
after ischemia-reperfusion. Biomed Pharmacother. 106:879–889. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Wang YY, Jiang H, Pan J, Huang XR, Wang
YC, Huang HF, To KF, Nikolic-Paterson DJ, Lan HY and Chen JH:
Macrophage-to-Myofibroblast transition contributes to interstitial
fibrosis in chronic renal allograft injury. J Am Soc Nephrol.
28:2053–2067. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Stephanou A, Brar BK, Scarabelli TM,
Jonassen AK, Yellon DM, Marber MS, Knight RA and Latchman DS:
Ischemia-induced STAT-1 expression and activation play a critical
role in cardiomyocyte apoptosis. J Biol Chem. 275:10002–10008.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
McCormick J, Suleman N, Scarabelli TM,
Knight RA, Latchman DS and Stephanou A: STAT1 deficiency in the
heart protects against myocardial infarction by enhancing
autophagy. J Cell Mol Med. 16:386–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Braga TT, Correa-Costa M, Guise YF,
Castoldi A, de Oliveira CD, Hyane MI, Cenedeze MA, Teixeira SA,
Muscara MN, Perez KR, et al: MyD88 signaling pathway is involved in
renal fibrosis by favoring a TH2 immune response and activating
alternative M2 macrophages. Mol Med. 18:1231–1239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Buchacher T, Ohradanova-Repic A,
Stockinger H, Fischer MB and Weber V: M2 polarization of human
macrophages favors survival of the intracellular pathogen chlamydia
pneumoniae. PLoS One. 10:e01435932015. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Lech M, Gröbmayr R, Ryu M, Lorenz G,
Hartter I, Mulay SR, Susanti HE, Kobayashi KS, Flavell RA and
Anders HJ: Macrophage phenotype controls long-term AKI
outcomes-kidney regeneration versus atrophy. J Am Soc Nephrol.
25:292–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Kemmner S, Bachmann Q, Steiger S, Lorenz
G, Honarpisheh M, Foresto-Neto O, Wang S, Carbajo-Lozoya J, Alt V,
Schulte C, et al: STAT1 regulates macrophage number and phenotype
and prevents renal fibrosis after ischemia-reperfusion injury. Am J
Physiol Renal Physiol. 316:F277–F291. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Dotor J, Lopez-Vazquez AB, Lasarte JJ,
Sarobe P, Garcia-Granero M, Riezu-Boj JI, Martinez A, Feijoo E,
Lopez-Sagaseta J, Hermida J, et al: Identification of peptide
inhibitors of transforming growth factor beta 1 using a
phage-displayed peptide library. Cytokine. 39:106–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Diaz-Valdes N, Basagoiti M, Dotor J,
Aranda F, Monreal I, Riezu-Boj JI, Borras-Cuesta F, Sarobe P and
Feijoo E: Induction of monocyte chemoattractant protein-1 and
interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration
and immunosuppression. Cancer Res. 71:812–821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Qiu SS, Dotor J and Hontanilla B: Effect
of P144® (Anti-TGF-β) in an ‘In Vivo’ human hypertrophic
scar model in nude mice. PLoS One. 10:e01444892015. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Baltanás A, Miguel-Carrasco JL, San José
G, Cebrián C, Moreno MU, Dotor J, Borrás-Cuesta F, López B,
González A, Díez J, et al: A synthetic peptide from transforming
growth Factor-β1 type III receptor inhibits NADPH oxidase and
prevents oxidative stress in the kidney of spontaneously
hypertensive rats. Antioxid Redox Signal. 19:1607–1618. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Li D, Zhang J, Yuan S, Wang C, Chang J,
Tong Y, Liu R, Sang T, Li L, Li J, et al: TGF-β1 peptide-based
inhibitor P144 ameliorates renal fibrosis after
ischemia-reperfusion injury by modulating alternatively activated
macrophages. Cell Prolif. 55:e132992022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Cao Q, Wang Y and Harris DCH: Macrophage
heterogeneity, phenotypes, and roles in renal fibrosis. Kidney Int
Suppl (2011). 4:16–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Zhang F, Fan L, Zhang H, Huang WJ, Sun D,
Pan BB, Wan X and Cao CC: Deficiency of IKK α in macrophages
mitigates fibrosis progression in the kidney after renal
ischemia-reperfusion injury. J Immunol Res. 2021:55210512021.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Saito H, Tanaka T, Tanaka S, Higashijima
Y, Yamaguchi J, Sugahara M, Ito M, Uchida L, Hasegawa S, Wakashima
T, et al: Persistent expression of neutrophil gelatinase-associated
lipocalin and M2 macrophage markers and chronic fibrosis after
acute kidney injury. Physiol Rep. 6:e137072018. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Sepe V, Libetta C, Gregorini M and Rampino
T: The innate immune system in human kidney inflammaging. J
Nephrol. 35:381–395. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Wen Y, Yan HR, Wang B and Liu BC:
Macrophage heterogeneity in kidney injury and fibrosis. Front
Immunol. 12:6817482021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Muraille E, Leo O and Moser M: TH1/TH2
paradigm extended: Macrophage polarization as an unappreciated
pathogen-driven escape mechanism? Front Immunol. 5:6032014.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Henderson NC, Mackinnon AC, Farnworth SL,
Kipari T, Haslett C, Iredale JP, Liu F-T, Hughes J and Sethi T:
Galectin-3 expression and secretion links macrophages to the
promotion of renal fibrosis. Am J Pathol. 172:288–298. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Meng XM, Wang S, Huang XR, Yang C, Xiao J,
Zhang Y, To KF, Nikolic-Paterson DJ and Lan HY: Inflammatory
macrophages can transdifferentiate into myofibroblasts during renal
fibrosis. Cell Death Dis. 7:e24952016. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Weis N, Weigert A, von Knethen A and Brüne
B: Heme oxygenase-1 contributes to an alternative macrophage
activation profile induced by apoptotic cell supernatants. Mol Biol
Cell. 20:1280–1288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zhang M, Nakamura K, Kageyama S, Lawal AO,
Gong KW, Bhetraratana M, Fujii T, Sulaiman D, Hirao H, Bolisetty S,
et al: Myeloid HO-1 modulates macrophage polarization and protects
against ischemia-reperfusion injury. JCI Insight. 3:1205962018.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Naito Y, Takagi T and Higashimura Y: Heme
oxygenase-1 and anti-inflammatory M2 macrophages. Arch Biochem
Biophysics. 564:83–88. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Ribeiro A, Dobosz E, Krill M, Kohler P,
Wadowska M, Steiger S, Schmaderer C, Koziel J and Lech M:
Macrophage-specific MCPIP1/Regnase-1 attenuates kidney
ischemia-reperfusion injury by shaping the local inflammatory
response and tissue regeneration. Cells. 11:3972022. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Satoh T, Takeuchi O, Vandenbon A, Yasuda
K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh
T, et al: The Jmjd3-Irf4 axis regulates M2 macrophage polarization
and host responses against helminth infection. Nat Immunol.
11:936–944. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Fu Y, Xiang Y, Li H, Chen A and Dong Z:
Inflammation in kidney repair: Mechanism and therapeutic potential.
Pharmacol Ther. 237:1082402022. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Bonventre JV and Zuk A: Ischemic acute
renal failure: An inflammatory disease? Kidney Int. 66:480–485.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Ferenbach DA and Bonventre JV: Mechanisms
of maladaptive repair after AKI leading to accelerated kidney
ageing and CKD. Nat Rev Nephrol. 11:264–276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Jiao B, An C, Tran M, Du H, Wang P, Zhou D
and Wang Y: Pharmacological inhibition of STAT6 ameliorates myeloid
fibroblast activation and alternative macrophage polarization in
renal fibrosis. Front Immunol. 12:7350142021. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Liang H, Zhang Z, Yan J and Wang Y, Hu Z,
Mitch WE and Wang Y: The IL-4 receptor α has a critical role in
bone marrow-derived fibroblast activation and renal fibrosis.
Kidney Int. 92:1433–1443. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Lehtonen A, Veckman V, Nikula T, Lahesmaa
R, Kinnunen L, Matikainen S and Julkunen I: Differential expression
of IFN regulatory factor 4 gene in human monocyte-derived dendritic
cells and macrophages. J Immunol. 175:6570–6579. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Hsu AT, Lupancu TJ, Lee M-C, Fleetwood AJ,
Cook AD, Hamilton JA and Achuthan A: Epigenetic and transcriptional
regulation of IL4-induced CCL17 production in human monocytes and
murine macrophages. J Biol Chemistry. 293:11415–11423. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Yamamoto M, Kato T, Hotta C, Nishiyama A,
Kurotaki D, Yoshinari M, Takami M, Ichino M, Nakazawa M, Matsuyama
T, et al: Shared and distinct functions of the transcription
factors IRF4 and IRF8 in myeloid cell development. PLoS One.
6:e258122011. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Sasaki K, Terker AS, Pan Y, Li Z, Cao S,
Wang Y, Niu A, Wang S, Fan X, Zhang MZ, et al: Deletion of myeloid
interferon regulatory factor 4 (Irf4) in mouse model protects
against kidney fibrosis after ischemic injury by decreased
macrophage recruitment and activation. J Am Soc Nephrol.
32:1037–1052. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Chen M, Wen X, Gao Y, Liu B, Zhong C, Nie
J and Liang H: IRF-4 deficiency reduces inflammation and kidney
fibrosis after folic acid-induced acute kidney injury. Int
Immunopharmacol. 100:1081422021. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Nelson MC and O'Connell RM: MicroRNAs: At
the interface of metabolic pathways and inflammatory responses by
macrophages. Front Immunol. 11:17972020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Niu X and Schulert GS: Functional
regulation of macrophage phenotypes by MicroRNAs in inflammatory
arthritis. Front Immunol. 10:22172019. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Luan J, Fu J, Wang D, Jiao C, Cui X, Chen
C, Liu D, Zhang Y, Wang Y, Yuen PST, et al: miR-150-based RNA
interference attenuates tubulointerstitial fibrosis through the
SOCS1/JAK/STAT pathway in vivo and in vitro. Mol Ther Nucleic
Acids. 22:871–884. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Hao X, Luan J, Jiao C, Ma C, Feng Z, Zhu
L, Zhang Y, Fu J, Lai E, Zhang B, et al: LNA-anti-miR-150
alleviates renal interstitial fibrosis by reducing pro-inflammatory
M1/M2 macrophage polarization. Front Immunol. 13:9130072022.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Li C, Ding XY, Xiang DM, Xu J, Huang XL,
Hou FF and Zhou QG: Enhanced M1 and Impaired M2 macrophage
polarization and reduced mitochondrial biogenesis via inhibition of
AMP kinase in chronic kidney disease. Cell Physiol Biochem.
36:358–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wen Y, Lu X, Ren J, Privratsky JR, Yang B,
Rudemiller NP, Zhang J, Griffiths R, Jain MK, Nedospasov SA, et al:
KLF4 in macrophages attenuates TNF α-mediated kidney injury and
fibrosis. J Am Soc Nephrol. 30:1925–1938. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Liu B, Nie J, Liang H, Liang Z, Huang J,
Yu W and Wen S: Pharmacological inhibition of SETD7 by PFI-2
attenuates renal fibrosis following folic acid and obstruction
injury. Eur J Pharmacol. 901:1740972021. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Debelle FD, Vanherweghem JL and Nortier
JL: Aristolochic acid nephropathy: A worldwide problem. Kidney Int.
74:158–169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Baudoux T, Jadot I, Declèves A-E, Antoine
M-H, Colet J-M, Botton O, De Prez E, Pozdzik A, Husson C, Caron N
and Nortier JL: Experimental aristolochic acid nephropathy: A
relevant model to study AKI-to-CKD transition. Front Med
(Lausanne). 9:8228702022. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Feng Y, Ren J, Gui Y, Wei W, Shu B, Lu Q,
Xue X, Sun X, He W, Yang J and Dai C: Wnt/β-catenin-promoted
macrophage alternative activation contributes to kidney fibrosis. J
Am Soc Nephrol. 29:182–193. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Wang X, Jia P, Ren T, Zou Z, Xu S, Zhang
Y, Shi Y, Bao S, Li Y, Fang Y and Ding X: MicroRNA-382 promotes
M2-like macrophage via the SIRP-α/STAT3 signaling pathway in
aristolochic acid-induced renal fibrosis. Front Immunol.
13:8649842022. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Martinez FO, Helming L, Milde R, Varin A,
Melgert BN, Draijer C, Thomas B, Fabbri M, Crawshaw A, Ho LP, et
al: Genetic programs expressed in resting and IL-4 alternatively
activated mouse and human macrophages: Similarities and
differences. Blood. 121:e57–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Chalayer E, Gramont B, Zekre F,
Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW and
Killian M: Fc receptors gone wrong: A comprehensive review of their
roles in autoimmune and inflammatory diseases. Autoimmun Rev.
21:1030162022. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Yadav N and Chandra H: Modulation of
alveolar macrophage innate response in proinflammatory-,
pro-oxidant-, and infection-models by mint extract and chemical
constituents: Role of MAPKs. Immunobiology. 223:49–56. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Formentini L, Santacatterina F, Nunez de
Arenas C, Stamatakis K, Lopez-Martinez D, Logan A, Fresno M, Smits
R, Murphy MP and Cuezva JM: Mitochondrial ROS production protects
the intestine from inflammation through functional M2 macrophage
polarization. Cell Rep. 19:1202–1213. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Phaniendra A, Jestadi DB and Periyasamy L:
Free radicals: Properties, sources, targets, and their implication
in various diseases. Indian J Clin Biochem. 30:11–26. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Zhang Y, Choksi S, Chen K, Pobezinskaya Y,
Linnoila I and Liu ZG: ROS play a critical role in the
differentiation of alternatively activated macrophages and the
occurrence of tumor-associated macrophages. Cell Res. 23:898–914.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Lebeau C, Debelle FD, Arlt VM, Pozdzik A,
De Prez EG, Phillips DH, Deschodt-Lanckman MM, Vanherweghem JL and
Nortier JL: Early proximal tubule injury in experimental
aristolochic acid nephropathy: Functional and histological studies.
Nephrol Dial Transplant. 20:2321–2332. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Seok JK, Lee SH, Kim MJ and Lee YM:
MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the
tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res.
42:8062–8072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Wang X, Xue N, Zhao S, Shi Y, Ding X and
Fang Y: Upregulation of miR-382 contributes to renal fibrosis
secondary to aristolochic acid-induced kidney injury via PTEN
signaling pathway. Cell Death Dis. 11:6202020. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Pan YF, Tan YX, Wang M, Zhang J, Zhang B,
Yang C, Ding ZW, Dong LW and Wang HY: Signal regulatory protein
alpha is associated with tumor-polarized macrophages phenotype
switch and plays a pivotal role in tumor progression. Hepatology.
58:680–691. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Sanz AB, Sanchez-Nino MD, Ramos AM, Moreno
JA, Santamaria B, Ruiz-Ortega M, Egido J and Ortiz A: NF-kappaB in
renal inflammation. J Am Soc Nephrol. 21:1254–1262. 2010.
View Article : Google Scholar : PubMed/NCBI
|
